Related Experiment Video
Updated: Jul 29, 2025

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
Published on: June 8, 2022
Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic
Nihar Jena1, Kinjal Patel2, Ronak Desai2
1Cardiovascular Medicine, St. Joseph Mercy Oakland Hospital, Pontiac, USA.
Abstract:
Prosthetic valve endocarditis (PVE) is an uncommon complication after heart valve replacement surgery that can result in increased morbidity and mortality. Current guidelines for management of PVE recommend antibiotic therapy followed by surgical valve replacement. The number of aortic valve replacements is expected to rise in the coming years with the expanded indications for use of transcatheter aortic valve replacement (TAVR) in patients with low, intermediate, and high surgical risk, as well as in patients with a failed aortic bioprosthetic valve. Current guidelines do not address the use of valve-in-valve (ViV) TAVR for management of PVE in patients who are at high risk for surgical intervention. The authors present a case of a patient with aortic valve PVE after surgical aortic valve replacement (SAVR); he was treated with valve-in-valve (ViV) TAVR due to the high surgical risk. The patient was discharged, but he returned to the hospital with PVE and valve dehiscence 14 months after ViV TAVR, after which he successfully underwent re-operative SAVR.
More Related Videos
Related Concept Videos
Endocarditis III: Medical Management
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Aortic Regurgitation III: Medical Management
Venous Thrombosis III: Interprofessional Care
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

